CHFR protein expression predicts outcomes to taxane-based first line therapy in metastatic NSCLC

PURPOSE: Currently, there is no clinically validated test for the prediction of response to tubulin-targeting agents in non-small cell lung cancer (NSCLC). Here, we investigated the significance of nuclear expression of the mitotic checkpoint gene checkpoint with forkhead and ringfinger domains (CHF...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Pillai, Rathi N, Brodie, Seth A, Sica, Gabriel L, Shaojin, You, Li, Ge, Nickleach, Dana C, Yuan, Liu, Varma, Vijay A, Bonta, Dacian, Herman, James G, Brock, Malcom V, Ribeiro, Maria JA, Ramalingam, Suresh S, Owonikoko, Taofeek K, Khuri, Fadlo R, Brandes, Johann C
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3602233/
https://ncbi.nlm.nih.gov/pubmed/23386692
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-12-2995
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados